Updated version of Nutritional Implications of Psychotropic Medications to be released this month

January 3, 2008

Did you know... that olanzapine (Zyprexa) may be associated with the

onset of binge eating disorder? That sibutramine (Meridia) may improve

symptoms of sleep apnea? That lamotrigine (Lamictal) may inhibit motility of

the oviducts, thus potentially affecting fertility? That mirtazapine (Remeron)

has been found to increase leptin levels?

That's the kind of information I just spent the last 6 months researching and

compiling in order to update my CD-rom.

You will have these references plus many, many more in the updated version of

Nutritional Implications of Psychotropic Medications. In addition to updates on

common medications, new fact sheets have been added for lisdexamfetamine

(Vyvanse), pregabalin (Lyrica), melatonin and ramelteon (Rozerem).

In addition to metabolic effects of these medications, I've included as many

off-label uses for each of these medications that I could find. It's important

not to assume that because someone is on a psych med, that they have a

psychiatric diagnosis. This information can be incorporated into counseling to

encourage medication compliance, which in turn enhances your value to your

treatment team.

This new publication will be ready to ship January 31, 2008. Any orders

received on or before this date will be charged the 2007 price ($34.95 plus

shipping), a $15 savings. (You won't be charged until your order is shipped).

I hope this reference (and my own obsessive-compulsive love of neuro research)

benefits and supports all of you in your clinical work!

Happy New Year to

Monika M. Woolsey

Recommended Posts